186 related articles for article (PubMed ID: 8689603)
1. Proto-RET is rearranged in the new human papillary thyroid cancer cell line PTC-1113A.
Herrmann ME
Cancer Genet Cytogenet; 1996 Jul; 89(1):14-20. PubMed ID: 8689603
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
[TBL] [Abstract][Full Text] [Related]
3. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
4. Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors.
Namba H; Yamashita S; Pei HC; Ishikawa N; Villadolid MC; Tominaga T; Kimura H; Tsuruta M; Yokoyama N; Izumi M
Endocrinol Jpn; 1991 Dec; 38(6):627-32. PubMed ID: 1823030
[TBL] [Abstract][Full Text] [Related]
5. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia.
Zou M; Shi Y; Farid NR
Cancer; 1994 Jan; 73(1):176-80. PubMed ID: 8275421
[TBL] [Abstract][Full Text] [Related]
6. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
[TBL] [Abstract][Full Text] [Related]
7. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene.
Tong Q; Li Y; Smanik PA; Fithian LJ; Xing S; Mazzaferri EL; Jhiang SM
Oncogene; 1995 May; 10(9):1781-7. PubMed ID: 7753554
[TBL] [Abstract][Full Text] [Related]
9. [Rearrangement of the RET gene in papillary thyroid carcinoma].
Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
[TBL] [Abstract][Full Text] [Related]
10. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
Grieco M; Santoro M; Berlingieri MT; Melillo RM; Donghi R; Bongarzone I; Pierotti MA; Della Porta G; Fusco A; Vecchio G
Cell; 1990 Feb; 60(4):557-63. PubMed ID: 2406025
[TBL] [Abstract][Full Text] [Related]
11. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.
Fabien N; Paulin C; Santoro M; Berger N; Grieco M; Galvain D; Barbier Y; Dubois PM; Fusco A
Br J Cancer; 1992 Dec; 66(6):1094-8. PubMed ID: 1457350
[TBL] [Abstract][Full Text] [Related]
12. ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?
Sugg SL; Zheng L; Rosen IB; Freeman JL; Ezzat S; Asa SL
J Clin Endocrinol Metab; 1996 Sep; 81(9):3360-5. PubMed ID: 8784097
[TBL] [Abstract][Full Text] [Related]
13. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
14. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas.
Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY
J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668
[TBL] [Abstract][Full Text] [Related]
15. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
16. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
[TBL] [Abstract][Full Text] [Related]
18. [Radiation-induced thyroid carcinomas in children: high prevalence of RET rearrangement].
Rabes HM; Klugbauer S
Verh Dtsch Ges Pathol; 1997; 81():139-44. PubMed ID: 9474864
[TBL] [Abstract][Full Text] [Related]
19. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
[TBL] [Abstract][Full Text] [Related]
20. Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?
Soares P; Fonseca E; Wynford-Thomas D; Sobrinho-Simões M
J Pathol; 1998 May; 185(1):71-8. PubMed ID: 9713362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
